Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, November 7th. Analysts expect the company to announce earnings of ($0.46) per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link. Iovance Biotherapeutics […]
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report)’s share price rose 5.7% during trading on Monday . The stock traded as high as $3.75 and last traded at $3.70. Approximately 229,723 shares traded hands during mid-day trading, a decline of 96% from the average daily volume of 5,219,849 shares. The stock had previously closed at […]
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report)’s stock price dropped 4.1% during mid-day trading on Monday . The company traded as low as $4.64 and last traded at $4.67. Approximately 4,890,713 shares traded hands during trading, a decline of 6% from the average daily volume of 5,192,396 shares. The stock had previously closed at […]
Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) had its price objective cut by Barclays from $40.00 to $18.00 in a report published on Monday, Marketbeat.com reports. They currently have an overweight rating on the biotechnology company’s stock. Other equities analysts have also issued research reports about the stock. Chardan Capital restated a buy rating and set […]
HC Wainwright reaffirmed their buy rating on shares of Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) in a research note published on Friday, Benzinga reports. HC Wainwright currently has a $38.00 price target on the biotechnology company’s stock. Other analysts also recently issued reports about the stock. Truist Financial reaffirmed a buy rating and set a […]